en English
en Englishfr Frenchde Germanit Italianru Russianes Spanish

Wordline shares surge on report Credit Agricole could take stake

Wordline shares surge on report Credit Agricole could take stake By Reuters

Breaking News

‘;

Stock Markets

Published Dec 01, 2023 07:37AM ET

© Reuters. FILE PHOTO: The logo of payments company Worldline is seen at the company headquarters in the financial and business district of La Defense, near Paris, France, October 26, 2023. REUTERS/Gonzalo Fuentes/File Photo

PARIS (Reuters) – Shares in Worldline surged almost 12% on Friday after a media report said Credit Agricole (OTC:CRARY) was considering acquiring a stake in the French payment processing company.

The French lender is exploring building a stake in Worldline in an effort to help stabilise its struggling payments partner, Bloomberg reported, citing people familiar with the matter.

Other French financial institutions could also look at playing a role in Worldline’s future, Bloomberg added, citing some of the people.

Credit Agricole and Worldline declined to comment.

Earlier this year, the companies signed a binding agreement to set up a joint venture to provide payment services to businesses and their customers. They expect to receive the necessary approvals by the end of this year before launching in early 2024.

Shares in Worldline pared some of their initial gains to stand 5% higher at 1220 GMT.

The stock lost more than half its value in late October, sending ripples through the sector, after Worldline shocked investors with a cut to its full year financial targets due to the economic slowdown, particularly in Germany.

It also severed ties with some of its merchants to reduce risks citing an increase in cybercrime.

Italian payments company Nexi (BIT:NEXII) last month confirmed its guidance while the Netherlands’ Adyen (AS:ADYEN) reassured the market with its “more realistic” medium-term guidance.

Worldline shares have fallen more than 58% this year.

Wordline shares surge on report Credit Agricole could take stake

Our Apps



Terms And Conditions
Privacy Policy
Risk Warning
Do not sell my personal information

© 2007-2023 Fusion Media Limited. All Rights Reserved.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Morgan Stanley says PagerDuty stock is ‘too cheap to ignore’; Shares gain after earnings
Next post AstraZeneca halts Phase III trials for kidney disease treatment